HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eric M Ammann Selected Research

Eric M Ammann Research Topics

Disease

4Multiple Myeloma
03/2024 - 01/2016
2Ischemic Stroke
01/2020 - 01/2016
2Chronic Renal Insufficiency
01/2020 - 01/2020
2Atrial Fibrillation
01/2020 - 01/2020
2Hemorrhage
01/2020 - 04/2019
2Obesity
10/2019 - 07/2019
2Overweight
10/2019 - 01/2019
2Type 2 Diabetes Mellitus (MODY)
01/2019 - 01/2019
2Venous Thromboembolism
02/2018 - 01/2016
2Myocardial Infarction
01/2018 - 01/2016
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
12/2017 - 01/2016
2Hematologic Neoplasms (Hematological Malignancy)
11/2017 - 01/2016
1Hypertension (High Blood Pressure)
02/2023
1Disease Progression
01/2023
1Embolism (Embolus)
01/2020
1Body Weight (Weight, Body)
10/2019
1Back Pain (Backache)
10/2019
1Chronic Pain
10/2019
1Arthralgia (Joint Pain)
10/2019
1Neuralgia (Stump Neuralgia)
10/2019
1Pain (Aches)
10/2019
1Anastomotic Leak
04/2019
1Surgical Wound Infection
04/2019
1Dementia (Dementias)
06/2017
1Infections
01/2016
1Agammaglobulinemia (Hypogammaglobulinemia)
01/2016
1Depressive Disorder (Melancholia)
07/2014

Drug/Important Bio-Agent (IBA)

4Intravenous Immunoglobulins (IVIG)FDA Link
02/2018 - 01/2016
2Dexamethasone (Maxidex)FDA LinkGeneric
03/2024 - 12/2020
2Lenalidomide (CC 5013)FDA Link
03/2024 - 12/2020
2daratumumabIBA
03/2024 - 12/2020
2Warfarin (Coumadin)FDA LinkGeneric
01/2020 - 01/2020
2RivaroxabanIBA
01/2020 - 01/2020
1Bortezomib (Velcade)FDA Link
03/2024
1Antihypertensive Agents (Antihypertensives)IBA
02/2023
1Factor Xa InhibitorsIBA
01/2020
1Opioid Analgesics (Opioids)IBA
10/2019
1Insulin (Novolin)FDA Link
01/2019
1Vitamin DFDA LinkGeneric
11/2017
1CalciumIBA
11/2017
1Eicosapentaenoic AcidIBA
06/2017
1Docosahexaenoic AcidsIBA
06/2017
1Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
06/2017
1Antidepressive Agents (Antidepressants)IBA
07/2014

Therapy/Procedure

3Therapeutics
02/2023 - 12/2017
2Bariatric Surgery
07/2019 - 01/2019
1Herniorrhaphy
07/2019
1Length of Stay
04/2019